The Centre told the Supreme Court on Saturday that a coronavirus vaccine developed by Indian pharmaceutical company Zydus Cadila will soon...
The Centre told the Supreme Court on Saturday that a coronavirus vaccine developed by Indian pharmaceutical company Zydus Cadila will soon be available for children aged 12-18 years, reported NDTV.
In an affidavit to the top court, the central government also said 186.6 crore vaccine shots are needed to inoculate residents aged above 18 years. It said that the 135 crore doses of Covid-19 vaccines will be available by December 2021, reported India Today.
However, this projection is quite less than the Centre’s earlier estimation of how many doses would be available. In May, the health ministry had said that India would have 216 crore doses of Covid-19 shots between August and December to vaccinate all adults. The difference in projection stands at 81 crore.
The Centre also told the court that efforts were underway to completely vaccinate all adults by December 31. “Out of this requirement, 51.6 crore doses will be made available for administration by July 31, 2021 leaving a requirement of approximately 135 crore vaccine doses for complete vaccination to the eligible population,” the affidavit said.
Out of the 135 crore, 50 crore vaccines will be from Covishield and 40 crore from Covaxin. Russia’s Sputnik V vaccine is estimated at 10 crores. Biological E Sub will also provide 30 crore doses...
